Michael Barbella, Managing Editor12.02.23
New products, new partnerships, and new ventures drove the bulk of new holiday season traffic on the ODT website this past week.
Smith+Nephew led the way with news of its purchase of knee regenerative technology developer CartiHeal for $180 million cash at closing and an additional $150 million, contingent on financial performance. CartiHeal's Agili-C is an off-the-shelf one-step treatment for osteochondral (bone and cartilage) lesions with a broader indication than existing treatments. It treats a wide patient population, including those with lesions in knees with mild to moderate osteoarthritis, a previously unaddressed condition, as well as the approximately 700,000 U.S. patients1 that receive cartilage repair annually.
NuVasive and Zimmer Biomet enticed cybervisitors to the site with word of their pending participation in the MedAccred accreditation program, while Pristine Surgical, Monogram Orthopedics, and Spinal Elements followed suit with new product announcements.
Pristine Surgical fully launched its Summit 4K single-use arthroscope, reportedly the first of its kind. The sterile 4K arthroscope removes the setup and teardown process and reprocessing needed for reusable arthroscopes and comes with Pristine Connect, software for cloud-connected surgical image and video storage and automated inventory management, as well.
Monogram Orthopedics, meanwhile, delivered its mBôs surgical robot to one of the largest global robotics distributors. The mBôs autonomously executes optimized paths for high-precision implant insertion in synthetic bone. With the mBôs robot, Monogram aims to help drive the next wave of robotic adaption in orthopedics by combining ease of use, safety, broad clinical functionality, cost, and novel implant design.
Finally, Spinal Elements garnered pageviews for releasing its Ventana 3D-printed interbody portfolio, which includes the Ventana C anterior cervical interbody system, Ventana P/T posterior lumbar interbody system, and Ventana L lateral lumbar interbody system. The Ventana portfolio features an implant architecture that maximizes bone graft volume and containment via a specialized 3D printing process.
Smith+Nephew led the way with news of its purchase of knee regenerative technology developer CartiHeal for $180 million cash at closing and an additional $150 million, contingent on financial performance. CartiHeal's Agili-C is an off-the-shelf one-step treatment for osteochondral (bone and cartilage) lesions with a broader indication than existing treatments. It treats a wide patient population, including those with lesions in knees with mild to moderate osteoarthritis, a previously unaddressed condition, as well as the approximately 700,000 U.S. patients1 that receive cartilage repair annually.
NuVasive and Zimmer Biomet enticed cybervisitors to the site with word of their pending participation in the MedAccred accreditation program, while Pristine Surgical, Monogram Orthopedics, and Spinal Elements followed suit with new product announcements.
Pristine Surgical fully launched its Summit 4K single-use arthroscope, reportedly the first of its kind. The sterile 4K arthroscope removes the setup and teardown process and reprocessing needed for reusable arthroscopes and comes with Pristine Connect, software for cloud-connected surgical image and video storage and automated inventory management, as well.
Monogram Orthopedics, meanwhile, delivered its mBôs surgical robot to one of the largest global robotics distributors. The mBôs autonomously executes optimized paths for high-precision implant insertion in synthetic bone. With the mBôs robot, Monogram aims to help drive the next wave of robotic adaption in orthopedics by combining ease of use, safety, broad clinical functionality, cost, and novel implant design.
Finally, Spinal Elements garnered pageviews for releasing its Ventana 3D-printed interbody portfolio, which includes the Ventana C anterior cervical interbody system, Ventana P/T posterior lumbar interbody system, and Ventana L lateral lumbar interbody system. The Ventana portfolio features an implant architecture that maximizes bone graft volume and containment via a specialized 3D printing process.